Actively Recruiting

Age: 1Minute - 10Years
All Genders
NCT04117685

Global Hip Dysplasia Registry

Led by University of British Columbia · Updated on 2024-11-18

5000

Participants Needed

1

Research Sites

643 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Developmental dysplasia of the hip (DDH) is the most common hip condition affecting infants and children. DDH represents a spectrum of issues affecting the hip joint - a "ball-and-socket" joint. When the femoral head (the "ball) is seated properly in the acetabulum (the "socket"), the hip is stable and can develop normally. However, when the femoral head is not well-seated, the hip can become unstable or dislocate. This instability or dislocation of the femoral head prevents the hip joint from developing normally during infancy and early childhood. If left undetected or untreated, it can lead to debilitating complications later in life. Development of a comprehensive, prospective international registry for all infants and children with DDH will provide the potential to impact all infants born, not only in British Columbia, but around the world. The purpose of this initiative is to identify best practices and standardize treatment and management strategies in order to optimize clinical and functional outcomes for patients with DDH. This registry includes targeted specific outcomes that will be investigated, in addition to the general collection of data on all patients diagnosed with any form of DDH up to the age of 10 years.

CONDITIONS

Official Title

Global Hip Dysplasia Registry

Who Can Participate

Age: 1Minute - 10Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Between the ages of 0 and 10 years at time of initial diagnosis
  • Referred for DDH screening due to specific risk factors or diagnosed with DDH
  • Diagnosis confirmed with appropriate ultrasonographic or radiographic imaging
Not Eligible

You will not qualify if you...

  • Known or suspected neuromuscular, collagen, chromosomal, or lower extremity congenital anomalies
  • Teratologic hip dislocation (syndromic-associated dislocations)
  • Over 10 years of age at initial diagnosis
  • Received prior treatment for DDH without appropriate imaging or documentation

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

British Columbia Children's Hospital

Vancouver, British Columbia, Canada, V6H 3N1

Actively Recruiting

Loading map...

Research Team

E

Emily K Schaeffer, PhD

CONTACT

A

Ashley L Munoz, BSc

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

3

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here